Experimental Models of Composite Tissue Allograft Transplants

ABSTRACT

Composite tissue allotransplantation has been recently introduced as a potential clinical treatment for complex reconstructive procedures including traumatic injuries, cancer ablative surgeries, or extensive tissue loss secondary to burns. Composite tissue allografts (CTAs) consist of heterogeneous tissues including skin, fat, muscle, nerves, lymph nodes, bone, cartilage, ligaments, and bone marrow with different antigenicities. Thus, composite tissue structure is considered to be more immunogenic than solid organ transplants. In this article, we present the experimental applications of CTA transplantation. To study the mechanisms of CTA acceptance and rejection, different experimental models, strategies, and different immunosuppressive protocols were used.

KEYWORDS

Composite tissue allotransplantation - experimental models - limb - face - vascularized bone

REFERENCES

• 1 Gorantla V, Maldonado C, Frank J, Barker J H. Composite tissue allotransplantation (CTA): current status and future insights.  Eur J Trauma. 2001;  27 267-274
• 2 Siemionow M, Ozer K. Advances in composite tissue allograft transplantation as related to the hand and upper extremity.  J Hand Surg [Am]. 2002;  27 565-580
• 3 Siemionow M, Oke R, Ozer K et al.. Induction of donor-specific tolerance in rat hind limb allografts under antilymphocyte serum and cyclosporine A protocol.  J Hand Surg [Am]. 2002;  27 1095-1103
• 4 Ozer K, Gurunluoglu R, Zielinski M, Izycki D, Unsal M, Siemionow M. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy.  J Reconstr Microsurg. 2003;  19 249-256
• 5 Ozer K, Izycki D, Zielinski M et al.. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.  Microsurgery. 2004;  24 248-254
• 6 Siemionow M Z, Izycki D M, Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.  Transplantation. 2003;  76 1662-1668
• 7 Ozer K, Oke R, Gurunluoglu R et al.. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.  Transplantation. 2003;  75 31-36
• 8 Siemionow M, Izycki D, Ozer K et al.. Role of thymus in operational tolerance induction in limb allograft transplant model.  Transplantation. 2006;  81 1568-1576
• 9 Ozer K, Zielinski M, Siemionow M. New composite tissue allograft transplantation model in mouse with intravital microscopic evaluation of microcirculation.  J Reconstr Microsurg. 2003;  19 323-330
• 10 Ozer K, Siemionow M. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants.  J Reconstr Microsurg. 2001;  17 511-517
• 11 Siemionow M, Ulusal B G, Ozmen S et al.. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation.  Microsurgery. 2004;  24 200-206
• 12 Ozmen S, Ulusal B G, Ulusal A E et al.. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.  Ann Plast Surg. 2006;  56 295-300
• 13 Siemionow M, Ozer K, Izycki D et al.. A new method of bone marrow transplantation leads to extension of skin allograft survival.  Transplant Proc. 2005;  37 2309-2314
• 14 Siemionow M Z, Klimczak A, Unal S. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.  Transplant Proc. 2005;  37 62-64
• 15 Siemionow M, Klimczak A, Unal S. Different routes of donor derived hematopoietic stem cells transplantation for donor specific chimerism induction across MHC barrier. Paper presented at: The 20th International Congress of the Transplantation Society September 5-10, 2004 Vienna, Austria;
• 16 Demir Y, Ozmen S, Klimczak A et al.. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.  Microsurgery. 2005;  25 415-422
• 17 Demir Y, Ozmen S, Klimczak A et al.. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.  Microsurgery. 2005;  25 415-422
• 18 Siemionow M, Ulusal B G, Ozmen S et al.. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation.  Microsurgery. 2004;  24 200-206
• 19 Agaoglu G, Unal S, Siemionow M. Transplantation of the vascularized bone allograft into the inguinal region.  Plast Reconstr Surg. 2005;  115 1794-1795
• 20 Agaoglu G, Carnevale K A, Zins J E, Siemionow M. Bilateral vascularized femoral bone transplant: a new model of vascularized bone marrow transplantation in rats, Part I.  Ann Plast Surg. 2006;  56 658-664
• 21 Klimczak A, Agaoglu G, Carnevale K A, Siemionow M. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.  Ann Plast Surg. 2006;  57 422-430
• 22 Agaoglu G, Siemionow M. Combined semimembranosus muscle and epigastric skin flap: a new model of composite-free flap in the rat.  Ann Plast Surg. 2005;  55 310-315
• 23 Strome S, Sloman-Moll E, Samonte B R et al.. Rat model for a vascularized laryngeal allograft.  Ann Otol Rhinol Laryngol. 1992;  101 950-953
• 24 Lorenz R R, Dan O, Fritz M A et al.. Rat laryngeal transplant model: technical advancements and a redefined rejection grading system.  Ann Otol Rhinol Laryngol. 2002;  111(12 Pt 1) 1120-1127
• 25 Akst L M, Siemionow M, Dan O et al.. Induction of tolerance in a rat model of laryngeal transplantation.  Transplantation. 2003;  27;76 1763-1770
• 26 Siemionow M, Gozel-Ulusal B, Engin Ulusal A et al.. Functional tolerance following face transplantation in the rat.  Transplantation. 2003;  75 1607-1609
• 27 Ulusal B G, Ulusal A E, Ozmen S et al.. A new composite facial and scalp transplantation model in rats.  Plast Reconstr Surg. 2003;  112 1302-1311
• 28 Unal S, Agaoglu G, Zins J et al.. New surgical approach in facial transplantation extends survival of allograft recipients.  Ann Plast Surg. 2005;  55 297-303
• 29 Demir Y, Ozmen S, Klimczak A et al.. Tolerance induction in composite facial allograft transplantation in the rat model.  Plast Reconstr Surg. 2004;  114 1790-1801
• 30 Yazici I, Unal S, Siemionow M. Composite hemiface/calvaria transplantation model in rats.  Plast Reconstr Surg. 2006;  118 1321-1327
• 31 Yazici I, Carnevale K, Klimczak A, Siemionow M. A new rat model of maxilla allotransplantation.  Ann Plast Surg. 2007;  58 338-344
• 32 Kulahci Y, Klimczak A, Siemionow M. Long term survival of composite hemiface/mandible/tongue tissue allograft permitted by donor specific chimerism. Paper presented at: Annual Meeting of the American Society of Plastic Surgeons October 6-11, 2006 San Francisco, CA;